Madrigal Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $287,268 | $212,802 | $137,250 | $103,320 |
Gross Profit | 269,146 | 203,360 | 132,737 | 99,875 |
EBITDA | -113,832 | -38,640 | -69,562 | -55,554 |
EBIT | -114,190 | -39,017 | -69,941 | -55,917 |
Net Income | -114,190 | -42,281 | -73,238 | -59,416 |
Net Change In Cash | 287,268 | 212,802 | 137,250 | 103,320 |
Free Cash Flow | 78,993 | -47,052 | -88,891 | -104,681 |
Cash | 295,694 | 186,193 | 183,646 | 100,019 |
Basic Shares | 22,482 | 22,207 | 22,091 | 21,929 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $180,133 | $0 | $0 | $37 |
Gross Profit | 173,900 | -527 | -467 | 273 |
EBITDA | -450,125 | -360,391 | -290,919 | -242,077 |
EBIT | -451,221 | -360,918 | -291,386 | -242,482 |
Net Income | -465,892 | -373,630 | -295,350 | -241,078 |
Net Change In Cash | 180,133 | 0 | 0 | 37 |
Cost of Revenue | 295,280 | -17,735 | ||
Free Cash Flow | -457,034 | -325,709 | -225,074 | -184,126 |
Cash | 100,019 | 99,915 | 331,549 | 36,269 |
Basic Shares | 21,272 | 18,688 | 17,137 | 16,535 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$4.95 |
2025-06-30 | -$1.90 |
2025-03-31 | -$3.32 |
